DAX 30 Index Could Pullback on Recovery Fund Delay, AstraZeneca Shot Ban 2021-04-01 07:00:00 Daniel Moss, Analyst
DAX 30, EU Recovery Fund, AstraZeneca Vaccine, Coronavirus Cases, Restrictions – Talking Points:
Equity markets largely gained ground during APAC trade as investors mulled the prospect of additional US fiscal stimulus.
The delayed ratification of the EU Recovery Fund and a ban on AstraZeneca’s vaccine may weigh on the German DAX 30 index in the near term.
Asia-Pacific Recap
Equity markets gained ground during Asia-Pacific trade as investors digested President Biden’s $2.2 trillion infrastructure spending package proposal. Australia’s ASX 200 climbed 0.56% on better-than-expected retail sales data. Japan’s Nikkei 225 also moved higher, alongside Hong Kong’s Hang Seng Index and China’s CSI 300.